No. As of October 2026, Transgene Biotek Ltd (526139.BO) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Transgene Biotek Ltd does not pass Musaffa's business and financial screening criteria.
Transgene Biotek Ltd. is a biotechnology company, which manufactures and sells diagnostic kits. The company is headquartered in Medak, Telangana. The company is engaged in the research and development of vaccines, oncology, and new drug delivery technologies. Its portfolio of products includes oncology, autoimmunity, drug delivery and biogenetics. The firm offers TrabiAAV, which is a platform for the delivery of micro-ribonucleic acids (miRNAs), short hairpin RNA (ShRNAs), immunogens developing clinical significance in gene therapy and CRISPR/cas 9 technologies. Its monoclonal antibody therapy is the use of monoclonal antibodies to specifically bind to target cells. Its TrabiORAL drug is focused on delivering proteins and peptides orally for a variety of human diseases. Its TBL-1203 drug is used to strengthen cell-mediated immunity and complete the elimination of the human immunodeficiency virus (HIV), without any need for retroviral drug therapy. Its Tacrolimus drug suppresses the immune system and is mainly used to prevent rejection of transplanted organs.
Transgene Biotek Ltd 526139.BO
₹2.65 ₹0.29 (9.86%) 1D
Last Updated: Oct 12, 12:00 AM·BSE
Pricing for IN stocks is delayed by 24 hours
526139.BO Shariah Compliance
Screening Methodology: AAOIFI
As of October 2026, Transgene Biotek Ltd is classified as not halal.
NOT HALAL
Transgene Biotek Ltd (526139.BO) Chart
Fetching Price Chart...
Financial Metrics & Statements of Transgene Biotek Ltd (526139.BO)
FAQ's for Transgene Biotek Ltd (526139.BO)
As of October 2026, Transgene Biotek Ltd 526139.BO is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Transgene Biotek Ltd using these criteria to determine its compliance status.
Muslim investors may consider investing in Transgene Biotek Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Transgene Biotek Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Transgene Biotek Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Transgene Biotek Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Transgene Biotek Ltd (526139.BO)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.